ArticlePharmacoEconomics2021
Circulating Tumour DNA as a Potential Cost-Effective Biomarker to Reduce Adjuvant Chemotherapy Overtreatment in Stage II Colorectal Cancer.
Yat Hang To et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
18 papers cite it
this paperpooled itcites it